Global CRISPR-Cas9 Nuclease Supply, Demand and Key Producers, 2023-2029
The global CRISPR-Cas9 Nuclease market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global CRISPR-Cas9 Nuclease demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CRISPR-Cas9 Nuclease, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CRISPR-Cas9 Nuclease that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CRISPR-Cas9 Nuclease total market, 2018-2029, (USD Million)
Global CRISPR-Cas9 Nuclease total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CRISPR-Cas9 Nuclease total market, key domestic companies and share, (USD Million)
Global CRISPR-Cas9 Nuclease revenue by player and market share 2018-2023, (USD Million)
Global CRISPR-Cas9 Nuclease total market by End Use, CAGR, 2018-2029, (USD Million)
Global CRISPR-Cas9 Nuclease total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global CRISPR-Cas9 Nuclease market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, TriLink BioTechnologies, Qiagen, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Horizon Discovery Plc and Sigma Aldrich, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CRISPR-Cas9 Nuclease market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by End Use, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CRISPR-Cas9 Nuclease Market, By Region:
1. How big is the global CRISPR-Cas9 Nuclease market?
2. What is the demand of the global CRISPR-Cas9 Nuclease market?
3. What is the year over year growth of the global CRISPR-Cas9 Nuclease market?
4. What is the total value of the global CRISPR-Cas9 Nuclease market?
5. Who are the major players in the global CRISPR-Cas9 Nuclease market?
6. What are the growth factors driving the market demand?
This report studies the global CRISPR-Cas9 Nuclease demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CRISPR-Cas9 Nuclease, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CRISPR-Cas9 Nuclease that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CRISPR-Cas9 Nuclease total market, 2018-2029, (USD Million)
Global CRISPR-Cas9 Nuclease total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CRISPR-Cas9 Nuclease total market, key domestic companies and share, (USD Million)
Global CRISPR-Cas9 Nuclease revenue by player and market share 2018-2023, (USD Million)
Global CRISPR-Cas9 Nuclease total market by End Use, CAGR, 2018-2029, (USD Million)
Global CRISPR-Cas9 Nuclease total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global CRISPR-Cas9 Nuclease market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, TriLink BioTechnologies, Qiagen, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Horizon Discovery Plc and Sigma Aldrich, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CRISPR-Cas9 Nuclease market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by End Use, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CRISPR-Cas9 Nuclease Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Genome Editing
- Genetic Engineering
- gRNA Database/Gene Librar
- CRISPR Plasmid
- Human Stem Cells
- Genetically Modified Organisms/Crops
- Cell Line Engineering
- Biotechnology Companies
- Pharmaceutical Companies
- Academic Institutes
- Research and Development Institutes
- Thermo Fisher
- TriLink BioTechnologies
- Qiagen
- Editas Medicine
- Caribou Biosciences
- CRISPR therapeutics
- Intellia therapeutics, Inc.
- Horizon Discovery Plc
- Sigma Aldrich
- Genscript
- Integrated DNA Technologies
- New England Biolabs
- Origene Technologies
- Aldevron
- Takara Bio
1. How big is the global CRISPR-Cas9 Nuclease market?
2. What is the demand of the global CRISPR-Cas9 Nuclease market?
3. What is the year over year growth of the global CRISPR-Cas9 Nuclease market?
4. What is the total value of the global CRISPR-Cas9 Nuclease market?
5. Who are the major players in the global CRISPR-Cas9 Nuclease market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 CRISPR-Cas9 Nuclease Introduction
1.2 World CRISPR-Cas9 Nuclease Market Size & Forecast (2018 & 2022 & 2029)
1.3 World CRISPR-Cas9 Nuclease Total Market by Region (by Headquarter Location)
1.3.1 World CRISPR-Cas9 Nuclease Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.3 China CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.4 Europe CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.5 Japan CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.6 South Korea CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.7 ASEAN CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.8 India CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CRISPR-Cas9 Nuclease Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CRISPR-Cas9 Nuclease Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.2 World CRISPR-Cas9 Nuclease Consumption Value by Region
2.2.1 World CRISPR-Cas9 Nuclease Consumption Value by Region (2018-2023)
2.2.2 World CRISPR-Cas9 Nuclease Consumption Value Forecast by Region (2024-2029)
2.3 United States CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.4 China CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.5 Europe CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.6 Japan CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.7 South Korea CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.8 ASEAN CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.9 India CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
3 WORLD CRISPR-CAS9 NUCLEASE COMPANIES COMPETITIVE ANALYSIS
3.1 World CRISPR-Cas9 Nuclease Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CRISPR-Cas9 Nuclease Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CRISPR-Cas9 Nuclease in 2022
3.2.3 Global Concentration Ratios (CR8) for CRISPR-Cas9 Nuclease in 2022
3.3 CRISPR-Cas9 Nuclease Company Evaluation Quadrant
3.4 CRISPR-Cas9 Nuclease Market: Overall Company Footprint Analysis
3.4.1 CRISPR-Cas9 Nuclease Market: Region Footprint
3.4.2 CRISPR-Cas9 Nuclease Market: Company Product Type Footprint
3.4.3 CRISPR-Cas9 Nuclease Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CRISPR-Cas9 Nuclease Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CRISPR-Cas9 Nuclease Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: CRISPR-Cas9 Nuclease Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: CRISPR-Cas9 Nuclease Consumption Value Comparison
4.2.1 United States VS China: CRISPR-Cas9 Nuclease Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CRISPR-Cas9 Nuclease Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based CRISPR-Cas9 Nuclease Companies and Market Share, 2018-2023
4.3.1 United States Based CRISPR-Cas9 Nuclease Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023)
4.4 China Based Companies CRISPR-Cas9 Nuclease Revenue and Market Share, 2018-2023
4.4.1 China Based CRISPR-Cas9 Nuclease Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023)
4.5 Rest of World Based CRISPR-Cas9 Nuclease Companies and Market Share, 2018-2023
4.5.1 Rest of World Based CRISPR-Cas9 Nuclease Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023)
5 MARKET ANALYSIS BY END USE
5.1 World CRISPR-Cas9 Nuclease Market Size Overview by End Use: 2018 VS 2022 VS 2029
5.2 Segment Introduction by End Use
5.2.1 Genome Editing
5.2.2 Genetic Engineering
5.2.3 gRNA Database/Gene Librar
5.2.4 CRISPR Plasmid
5.2.5 Human Stem Cells
5.2.6 Genetically Modified Organisms/Crops
5.2.7 Cell Line Engineering
5.3 Market Segment by End Use
5.3.1 World CRISPR-Cas9 Nuclease Market Size by End Use (2018-2023)
5.3.2 World CRISPR-Cas9 Nuclease Market Size by End Use (2024-2029)
5.3.3 World CRISPR-Cas9 Nuclease Market Size Market Share by End Use (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CRISPR-Cas9 Nuclease Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Biotechnology Companies
6.2.2 Pharmaceutical Companies
6.2.3 Academic Institutes
6.2.4 Research and Development Institutes
6.2.5 Research and Development Institutes
6.3 Market Segment by Application
6.3.1 World CRISPR-Cas9 Nuclease Market Size by Application (2018-2023)
6.3.2 World CRISPR-Cas9 Nuclease Market Size by Application (2024-2029)
6.3.3 World CRISPR-Cas9 Nuclease Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Thermo Fisher
7.1.1 Thermo Fisher Details
7.1.2 Thermo Fisher Major Business
7.1.3 Thermo Fisher CRISPR-Cas9 Nuclease Product and Services
7.1.4 Thermo Fisher CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Recent Developments/Updates
7.1.6 Thermo Fisher Competitive Strengths & Weaknesses
7.2 TriLink BioTechnologies
7.2.1 TriLink BioTechnologies Details
7.2.2 TriLink BioTechnologies Major Business
7.2.3 TriLink BioTechnologies CRISPR-Cas9 Nuclease Product and Services
7.2.4 TriLink BioTechnologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 TriLink BioTechnologies Recent Developments/Updates
7.2.6 TriLink BioTechnologies Competitive Strengths & Weaknesses
7.3 Qiagen
7.3.1 Qiagen Details
7.3.2 Qiagen Major Business
7.3.3 Qiagen CRISPR-Cas9 Nuclease Product and Services
7.3.4 Qiagen CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Qiagen Recent Developments/Updates
7.3.6 Qiagen Competitive Strengths & Weaknesses
7.4 Editas Medicine
7.4.1 Editas Medicine Details
7.4.2 Editas Medicine Major Business
7.4.3 Editas Medicine CRISPR-Cas9 Nuclease Product and Services
7.4.4 Editas Medicine CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Editas Medicine Recent Developments/Updates
7.4.6 Editas Medicine Competitive Strengths & Weaknesses
7.5 Caribou Biosciences
7.5.1 Caribou Biosciences Details
7.5.2 Caribou Biosciences Major Business
7.5.3 Caribou Biosciences CRISPR-Cas9 Nuclease Product and Services
7.5.4 Caribou Biosciences CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Caribou Biosciences Recent Developments/Updates
7.5.6 Caribou Biosciences Competitive Strengths & Weaknesses
7.6 CRISPR therapeutics
7.6.1 CRISPR therapeutics Details
7.6.2 CRISPR therapeutics Major Business
7.6.3 CRISPR therapeutics CRISPR-Cas9 Nuclease Product and Services
7.6.4 CRISPR therapeutics CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 CRISPR therapeutics Recent Developments/Updates
7.6.6 CRISPR therapeutics Competitive Strengths & Weaknesses
7.7 Intellia therapeutics, Inc.
7.7.1 Intellia therapeutics, Inc. Details
7.7.2 Intellia therapeutics, Inc. Major Business
7.7.3 Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Product and Services
7.7.4 Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Intellia therapeutics, Inc. Recent Developments/Updates
7.7.6 Intellia therapeutics, Inc. Competitive Strengths & Weaknesses
7.8 Horizon Discovery Plc
7.8.1 Horizon Discovery Plc Details
7.8.2 Horizon Discovery Plc Major Business
7.8.3 Horizon Discovery Plc CRISPR-Cas9 Nuclease Product and Services
7.8.4 Horizon Discovery Plc CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Horizon Discovery Plc Recent Developments/Updates
7.8.6 Horizon Discovery Plc Competitive Strengths & Weaknesses
7.9 Sigma Aldrich
7.9.1 Sigma Aldrich Details
7.9.2 Sigma Aldrich Major Business
7.9.3 Sigma Aldrich CRISPR-Cas9 Nuclease Product and Services
7.9.4 Sigma Aldrich CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Sigma Aldrich Recent Developments/Updates
7.9.6 Sigma Aldrich Competitive Strengths & Weaknesses
7.10 Genscript
7.10.1 Genscript Details
7.10.2 Genscript Major Business
7.10.3 Genscript CRISPR-Cas9 Nuclease Product and Services
7.10.4 Genscript CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Genscript Recent Developments/Updates
7.10.6 Genscript Competitive Strengths & Weaknesses
7.11 Integrated DNA Technologies
7.11.1 Integrated DNA Technologies Details
7.11.2 Integrated DNA Technologies Major Business
7.11.3 Integrated DNA Technologies CRISPR-Cas9 Nuclease Product and Services
7.11.4 Integrated DNA Technologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Integrated DNA Technologies Recent Developments/Updates
7.11.6 Integrated DNA Technologies Competitive Strengths & Weaknesses
7.12 New England Biolabs
7.12.1 New England Biolabs Details
7.12.2 New England Biolabs Major Business
7.12.3 New England Biolabs CRISPR-Cas9 Nuclease Product and Services
7.12.4 New England Biolabs CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 New England Biolabs Recent Developments/Updates
7.12.6 New England Biolabs Competitive Strengths & Weaknesses
7.13 Origene Technologies
7.13.1 Origene Technologies Details
7.13.2 Origene Technologies Major Business
7.13.3 Origene Technologies CRISPR-Cas9 Nuclease Product and Services
7.13.4 Origene Technologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Origene Technologies Recent Developments/Updates
7.13.6 Origene Technologies Competitive Strengths & Weaknesses
7.14 Aldevron
7.14.1 Aldevron Details
7.14.2 Aldevron Major Business
7.14.3 Aldevron CRISPR-Cas9 Nuclease Product and Services
7.14.4 Aldevron CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Aldevron Recent Developments/Updates
7.14.6 Aldevron Competitive Strengths & Weaknesses
7.15 Takara Bio
7.15.1 Takara Bio Details
7.15.2 Takara Bio Major Business
7.15.3 Takara Bio CRISPR-Cas9 Nuclease Product and Services
7.15.4 Takara Bio CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Takara Bio Recent Developments/Updates
7.15.6 Takara Bio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CRISPR-Cas9 Nuclease Industry Chain
8.2 CRISPR-Cas9 Nuclease Upstream Analysis
8.3 CRISPR-Cas9 Nuclease Midstream Analysis
8.4 CRISPR-Cas9 Nuclease Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CRISPR-Cas9 Nuclease Introduction
1.2 World CRISPR-Cas9 Nuclease Market Size & Forecast (2018 & 2022 & 2029)
1.3 World CRISPR-Cas9 Nuclease Total Market by Region (by Headquarter Location)
1.3.1 World CRISPR-Cas9 Nuclease Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.3 China CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.4 Europe CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.5 Japan CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.6 South Korea CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.7 ASEAN CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.3.8 India CRISPR-Cas9 Nuclease Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CRISPR-Cas9 Nuclease Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CRISPR-Cas9 Nuclease Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.2 World CRISPR-Cas9 Nuclease Consumption Value by Region
2.2.1 World CRISPR-Cas9 Nuclease Consumption Value by Region (2018-2023)
2.2.2 World CRISPR-Cas9 Nuclease Consumption Value Forecast by Region (2024-2029)
2.3 United States CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.4 China CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.5 Europe CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.6 Japan CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.7 South Korea CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.8 ASEAN CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
2.9 India CRISPR-Cas9 Nuclease Consumption Value (2018-2029)
3 WORLD CRISPR-CAS9 NUCLEASE COMPANIES COMPETITIVE ANALYSIS
3.1 World CRISPR-Cas9 Nuclease Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CRISPR-Cas9 Nuclease Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CRISPR-Cas9 Nuclease in 2022
3.2.3 Global Concentration Ratios (CR8) for CRISPR-Cas9 Nuclease in 2022
3.3 CRISPR-Cas9 Nuclease Company Evaluation Quadrant
3.4 CRISPR-Cas9 Nuclease Market: Overall Company Footprint Analysis
3.4.1 CRISPR-Cas9 Nuclease Market: Region Footprint
3.4.2 CRISPR-Cas9 Nuclease Market: Company Product Type Footprint
3.4.3 CRISPR-Cas9 Nuclease Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CRISPR-Cas9 Nuclease Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CRISPR-Cas9 Nuclease Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: CRISPR-Cas9 Nuclease Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: CRISPR-Cas9 Nuclease Consumption Value Comparison
4.2.1 United States VS China: CRISPR-Cas9 Nuclease Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CRISPR-Cas9 Nuclease Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based CRISPR-Cas9 Nuclease Companies and Market Share, 2018-2023
4.3.1 United States Based CRISPR-Cas9 Nuclease Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023)
4.4 China Based Companies CRISPR-Cas9 Nuclease Revenue and Market Share, 2018-2023
4.4.1 China Based CRISPR-Cas9 Nuclease Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023)
4.5 Rest of World Based CRISPR-Cas9 Nuclease Companies and Market Share, 2018-2023
4.5.1 Rest of World Based CRISPR-Cas9 Nuclease Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023)
5 MARKET ANALYSIS BY END USE
5.1 World CRISPR-Cas9 Nuclease Market Size Overview by End Use: 2018 VS 2022 VS 2029
5.2 Segment Introduction by End Use
5.2.1 Genome Editing
5.2.2 Genetic Engineering
5.2.3 gRNA Database/Gene Librar
5.2.4 CRISPR Plasmid
5.2.5 Human Stem Cells
5.2.6 Genetically Modified Organisms/Crops
5.2.7 Cell Line Engineering
5.3 Market Segment by End Use
5.3.1 World CRISPR-Cas9 Nuclease Market Size by End Use (2018-2023)
5.3.2 World CRISPR-Cas9 Nuclease Market Size by End Use (2024-2029)
5.3.3 World CRISPR-Cas9 Nuclease Market Size Market Share by End Use (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CRISPR-Cas9 Nuclease Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Biotechnology Companies
6.2.2 Pharmaceutical Companies
6.2.3 Academic Institutes
6.2.4 Research and Development Institutes
6.2.5 Research and Development Institutes
6.3 Market Segment by Application
6.3.1 World CRISPR-Cas9 Nuclease Market Size by Application (2018-2023)
6.3.2 World CRISPR-Cas9 Nuclease Market Size by Application (2024-2029)
6.3.3 World CRISPR-Cas9 Nuclease Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Thermo Fisher
7.1.1 Thermo Fisher Details
7.1.2 Thermo Fisher Major Business
7.1.3 Thermo Fisher CRISPR-Cas9 Nuclease Product and Services
7.1.4 Thermo Fisher CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Recent Developments/Updates
7.1.6 Thermo Fisher Competitive Strengths & Weaknesses
7.2 TriLink BioTechnologies
7.2.1 TriLink BioTechnologies Details
7.2.2 TriLink BioTechnologies Major Business
7.2.3 TriLink BioTechnologies CRISPR-Cas9 Nuclease Product and Services
7.2.4 TriLink BioTechnologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 TriLink BioTechnologies Recent Developments/Updates
7.2.6 TriLink BioTechnologies Competitive Strengths & Weaknesses
7.3 Qiagen
7.3.1 Qiagen Details
7.3.2 Qiagen Major Business
7.3.3 Qiagen CRISPR-Cas9 Nuclease Product and Services
7.3.4 Qiagen CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Qiagen Recent Developments/Updates
7.3.6 Qiagen Competitive Strengths & Weaknesses
7.4 Editas Medicine
7.4.1 Editas Medicine Details
7.4.2 Editas Medicine Major Business
7.4.3 Editas Medicine CRISPR-Cas9 Nuclease Product and Services
7.4.4 Editas Medicine CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Editas Medicine Recent Developments/Updates
7.4.6 Editas Medicine Competitive Strengths & Weaknesses
7.5 Caribou Biosciences
7.5.1 Caribou Biosciences Details
7.5.2 Caribou Biosciences Major Business
7.5.3 Caribou Biosciences CRISPR-Cas9 Nuclease Product and Services
7.5.4 Caribou Biosciences CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Caribou Biosciences Recent Developments/Updates
7.5.6 Caribou Biosciences Competitive Strengths & Weaknesses
7.6 CRISPR therapeutics
7.6.1 CRISPR therapeutics Details
7.6.2 CRISPR therapeutics Major Business
7.6.3 CRISPR therapeutics CRISPR-Cas9 Nuclease Product and Services
7.6.4 CRISPR therapeutics CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 CRISPR therapeutics Recent Developments/Updates
7.6.6 CRISPR therapeutics Competitive Strengths & Weaknesses
7.7 Intellia therapeutics, Inc.
7.7.1 Intellia therapeutics, Inc. Details
7.7.2 Intellia therapeutics, Inc. Major Business
7.7.3 Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Product and Services
7.7.4 Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Intellia therapeutics, Inc. Recent Developments/Updates
7.7.6 Intellia therapeutics, Inc. Competitive Strengths & Weaknesses
7.8 Horizon Discovery Plc
7.8.1 Horizon Discovery Plc Details
7.8.2 Horizon Discovery Plc Major Business
7.8.3 Horizon Discovery Plc CRISPR-Cas9 Nuclease Product and Services
7.8.4 Horizon Discovery Plc CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Horizon Discovery Plc Recent Developments/Updates
7.8.6 Horizon Discovery Plc Competitive Strengths & Weaknesses
7.9 Sigma Aldrich
7.9.1 Sigma Aldrich Details
7.9.2 Sigma Aldrich Major Business
7.9.3 Sigma Aldrich CRISPR-Cas9 Nuclease Product and Services
7.9.4 Sigma Aldrich CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Sigma Aldrich Recent Developments/Updates
7.9.6 Sigma Aldrich Competitive Strengths & Weaknesses
7.10 Genscript
7.10.1 Genscript Details
7.10.2 Genscript Major Business
7.10.3 Genscript CRISPR-Cas9 Nuclease Product and Services
7.10.4 Genscript CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Genscript Recent Developments/Updates
7.10.6 Genscript Competitive Strengths & Weaknesses
7.11 Integrated DNA Technologies
7.11.1 Integrated DNA Technologies Details
7.11.2 Integrated DNA Technologies Major Business
7.11.3 Integrated DNA Technologies CRISPR-Cas9 Nuclease Product and Services
7.11.4 Integrated DNA Technologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Integrated DNA Technologies Recent Developments/Updates
7.11.6 Integrated DNA Technologies Competitive Strengths & Weaknesses
7.12 New England Biolabs
7.12.1 New England Biolabs Details
7.12.2 New England Biolabs Major Business
7.12.3 New England Biolabs CRISPR-Cas9 Nuclease Product and Services
7.12.4 New England Biolabs CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 New England Biolabs Recent Developments/Updates
7.12.6 New England Biolabs Competitive Strengths & Weaknesses
7.13 Origene Technologies
7.13.1 Origene Technologies Details
7.13.2 Origene Technologies Major Business
7.13.3 Origene Technologies CRISPR-Cas9 Nuclease Product and Services
7.13.4 Origene Technologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Origene Technologies Recent Developments/Updates
7.13.6 Origene Technologies Competitive Strengths & Weaknesses
7.14 Aldevron
7.14.1 Aldevron Details
7.14.2 Aldevron Major Business
7.14.3 Aldevron CRISPR-Cas9 Nuclease Product and Services
7.14.4 Aldevron CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Aldevron Recent Developments/Updates
7.14.6 Aldevron Competitive Strengths & Weaknesses
7.15 Takara Bio
7.15.1 Takara Bio Details
7.15.2 Takara Bio Major Business
7.15.3 Takara Bio CRISPR-Cas9 Nuclease Product and Services
7.15.4 Takara Bio CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Takara Bio Recent Developments/Updates
7.15.6 Takara Bio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CRISPR-Cas9 Nuclease Industry Chain
8.2 CRISPR-Cas9 Nuclease Upstream Analysis
8.3 CRISPR-Cas9 Nuclease Midstream Analysis
8.4 CRISPR-Cas9 Nuclease Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CRISPR-Cas9 Nuclease Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World CRISPR-Cas9 Nuclease Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World CRISPR-Cas9 Nuclease Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World CRISPR-Cas9 Nuclease Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World CRISPR-Cas9 Nuclease Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CRISPR-Cas9 Nuclease Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World CRISPR-Cas9 Nuclease Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World CRISPR-Cas9 Nuclease Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World CRISPR-Cas9 Nuclease Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key CRISPR-Cas9 Nuclease Players in 2022
Table 12. World CRISPR-Cas9 Nuclease Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global CRISPR-Cas9 Nuclease Company Evaluation Quadrant
Table 14. Head Office of Key CRISPR-Cas9 Nuclease Player
Table 15. CRISPR-Cas9 Nuclease Market: Company Product Type Footprint
Table 16. CRISPR-Cas9 Nuclease Market: Company Product Application Footprint
Table 17. CRISPR-Cas9 Nuclease Mergers & Acquisitions Activity
Table 18. United States VS China CRISPR-Cas9 Nuclease Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China CRISPR-Cas9 Nuclease Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based CRISPR-Cas9 Nuclease Companies, Headquarters (States, Country)
Table 21. United States Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies CRISPR-Cas9 Nuclease Revenue Market Share (2018-2023)
Table 23. China Based CRISPR-Cas9 Nuclease Companies, Headquarters (Province, Country)
Table 24. China Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies CRISPR-Cas9 Nuclease Revenue Market Share (2018-2023)
Table 26. Rest of World Based CRISPR-Cas9 Nuclease Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies CRISPR-Cas9 Nuclease Revenue Market Share (2018-2023)
Table 29. World CRISPR-Cas9 Nuclease Market Size by End Use, (USD Million), 2018 & 2022 & 2029
Table 30. World CRISPR-Cas9 Nuclease Market Size by End Use (2018-2023) & (USD Million)
Table 31. World CRISPR-Cas9 Nuclease Market Size by End Use (2024-2029) & (USD Million)
Table 32. World CRISPR-Cas9 Nuclease Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World CRISPR-Cas9 Nuclease Market Size by Application (2018-2023) & (USD Million)
Table 34. World CRISPR-Cas9 Nuclease Market Size by Application (2024-2029) & (USD Million)
Table 35. Thermo Fisher Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Major Business
Table 37. Thermo Fisher CRISPR-Cas9 Nuclease Product and Services
Table 38. Thermo Fisher CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Thermo Fisher Recent Developments/Updates
Table 40. Thermo Fisher Competitive Strengths & Weaknesses
Table 41. TriLink BioTechnologies Basic Information, Area Served and Competitors
Table 42. TriLink BioTechnologies Major Business
Table 43. TriLink BioTechnologies CRISPR-Cas9 Nuclease Product and Services
Table 44. TriLink BioTechnologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. TriLink BioTechnologies Recent Developments/Updates
Table 46. TriLink BioTechnologies Competitive Strengths & Weaknesses
Table 47. Qiagen Basic Information, Area Served and Competitors
Table 48. Qiagen Major Business
Table 49. Qiagen CRISPR-Cas9 Nuclease Product and Services
Table 50. Qiagen CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Qiagen Recent Developments/Updates
Table 52. Qiagen Competitive Strengths & Weaknesses
Table 53. Editas Medicine Basic Information, Area Served and Competitors
Table 54. Editas Medicine Major Business
Table 55. Editas Medicine CRISPR-Cas9 Nuclease Product and Services
Table 56. Editas Medicine CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Editas Medicine Recent Developments/Updates
Table 58. Editas Medicine Competitive Strengths & Weaknesses
Table 59. Caribou Biosciences Basic Information, Area Served and Competitors
Table 60. Caribou Biosciences Major Business
Table 61. Caribou Biosciences CRISPR-Cas9 Nuclease Product and Services
Table 62. Caribou Biosciences CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Caribou Biosciences Recent Developments/Updates
Table 64. Caribou Biosciences Competitive Strengths & Weaknesses
Table 65. CRISPR therapeutics Basic Information, Area Served and Competitors
Table 66. CRISPR therapeutics Major Business
Table 67. CRISPR therapeutics CRISPR-Cas9 Nuclease Product and Services
Table 68. CRISPR therapeutics CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. CRISPR therapeutics Recent Developments/Updates
Table 70. CRISPR therapeutics Competitive Strengths & Weaknesses
Table 71. Intellia therapeutics, Inc. Basic Information, Area Served and Competitors
Table 72. Intellia therapeutics, Inc. Major Business
Table 73. Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Product and Services
Table 74. Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Intellia therapeutics, Inc. Recent Developments/Updates
Table 76. Intellia therapeutics, Inc. Competitive Strengths & Weaknesses
Table 77. Horizon Discovery Plc Basic Information, Area Served and Competitors
Table 78. Horizon Discovery Plc Major Business
Table 79. Horizon Discovery Plc CRISPR-Cas9 Nuclease Product and Services
Table 80. Horizon Discovery Plc CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Horizon Discovery Plc Recent Developments/Updates
Table 82. Horizon Discovery Plc Competitive Strengths & Weaknesses
Table 83. Sigma Aldrich Basic Information, Area Served and Competitors
Table 84. Sigma Aldrich Major Business
Table 85. Sigma Aldrich CRISPR-Cas9 Nuclease Product and Services
Table 86. Sigma Aldrich CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sigma Aldrich Recent Developments/Updates
Table 88. Sigma Aldrich Competitive Strengths & Weaknesses
Table 89. Genscript Basic Information, Area Served and Competitors
Table 90. Genscript Major Business
Table 91. Genscript CRISPR-Cas9 Nuclease Product and Services
Table 92. Genscript CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Genscript Recent Developments/Updates
Table 94. Genscript Competitive Strengths & Weaknesses
Table 95. Integrated DNA Technologies Basic Information, Area Served and Competitors
Table 96. Integrated DNA Technologies Major Business
Table 97. Integrated DNA Technologies CRISPR-Cas9 Nuclease Product and Services
Table 98. Integrated DNA Technologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Integrated DNA Technologies Recent Developments/Updates
Table 100. Integrated DNA Technologies Competitive Strengths & Weaknesses
Table 101. New England Biolabs Basic Information, Area Served and Competitors
Table 102. New England Biolabs Major Business
Table 103. New England Biolabs CRISPR-Cas9 Nuclease Product and Services
Table 104. New England Biolabs CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. New England Biolabs Recent Developments/Updates
Table 106. New England Biolabs Competitive Strengths & Weaknesses
Table 107. Origene Technologies Basic Information, Area Served and Competitors
Table 108. Origene Technologies Major Business
Table 109. Origene Technologies CRISPR-Cas9 Nuclease Product and Services
Table 110. Origene Technologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Origene Technologies Recent Developments/Updates
Table 112. Origene Technologies Competitive Strengths & Weaknesses
Table 113. Aldevron Basic Information, Area Served and Competitors
Table 114. Aldevron Major Business
Table 115. Aldevron CRISPR-Cas9 Nuclease Product and Services
Table 116. Aldevron CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Aldevron Recent Developments/Updates
Table 118. Takara Bio Basic Information, Area Served and Competitors
Table 119. Takara Bio Major Business
Table 120. Takara Bio CRISPR-Cas9 Nuclease Product and Services
Table 121. Takara Bio CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of CRISPR-Cas9 Nuclease Upstream (Raw Materials)
Table 123. CRISPR-Cas9 Nuclease Typical Customers
Table 1. World CRISPR-Cas9 Nuclease Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World CRISPR-Cas9 Nuclease Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World CRISPR-Cas9 Nuclease Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World CRISPR-Cas9 Nuclease Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World CRISPR-Cas9 Nuclease Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CRISPR-Cas9 Nuclease Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World CRISPR-Cas9 Nuclease Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World CRISPR-Cas9 Nuclease Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World CRISPR-Cas9 Nuclease Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key CRISPR-Cas9 Nuclease Players in 2022
Table 12. World CRISPR-Cas9 Nuclease Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global CRISPR-Cas9 Nuclease Company Evaluation Quadrant
Table 14. Head Office of Key CRISPR-Cas9 Nuclease Player
Table 15. CRISPR-Cas9 Nuclease Market: Company Product Type Footprint
Table 16. CRISPR-Cas9 Nuclease Market: Company Product Application Footprint
Table 17. CRISPR-Cas9 Nuclease Mergers & Acquisitions Activity
Table 18. United States VS China CRISPR-Cas9 Nuclease Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China CRISPR-Cas9 Nuclease Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based CRISPR-Cas9 Nuclease Companies, Headquarters (States, Country)
Table 21. United States Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies CRISPR-Cas9 Nuclease Revenue Market Share (2018-2023)
Table 23. China Based CRISPR-Cas9 Nuclease Companies, Headquarters (Province, Country)
Table 24. China Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies CRISPR-Cas9 Nuclease Revenue Market Share (2018-2023)
Table 26. Rest of World Based CRISPR-Cas9 Nuclease Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CRISPR-Cas9 Nuclease Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies CRISPR-Cas9 Nuclease Revenue Market Share (2018-2023)
Table 29. World CRISPR-Cas9 Nuclease Market Size by End Use, (USD Million), 2018 & 2022 & 2029
Table 30. World CRISPR-Cas9 Nuclease Market Size by End Use (2018-2023) & (USD Million)
Table 31. World CRISPR-Cas9 Nuclease Market Size by End Use (2024-2029) & (USD Million)
Table 32. World CRISPR-Cas9 Nuclease Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World CRISPR-Cas9 Nuclease Market Size by Application (2018-2023) & (USD Million)
Table 34. World CRISPR-Cas9 Nuclease Market Size by Application (2024-2029) & (USD Million)
Table 35. Thermo Fisher Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Major Business
Table 37. Thermo Fisher CRISPR-Cas9 Nuclease Product and Services
Table 38. Thermo Fisher CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Thermo Fisher Recent Developments/Updates
Table 40. Thermo Fisher Competitive Strengths & Weaknesses
Table 41. TriLink BioTechnologies Basic Information, Area Served and Competitors
Table 42. TriLink BioTechnologies Major Business
Table 43. TriLink BioTechnologies CRISPR-Cas9 Nuclease Product and Services
Table 44. TriLink BioTechnologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. TriLink BioTechnologies Recent Developments/Updates
Table 46. TriLink BioTechnologies Competitive Strengths & Weaknesses
Table 47. Qiagen Basic Information, Area Served and Competitors
Table 48. Qiagen Major Business
Table 49. Qiagen CRISPR-Cas9 Nuclease Product and Services
Table 50. Qiagen CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Qiagen Recent Developments/Updates
Table 52. Qiagen Competitive Strengths & Weaknesses
Table 53. Editas Medicine Basic Information, Area Served and Competitors
Table 54. Editas Medicine Major Business
Table 55. Editas Medicine CRISPR-Cas9 Nuclease Product and Services
Table 56. Editas Medicine CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Editas Medicine Recent Developments/Updates
Table 58. Editas Medicine Competitive Strengths & Weaknesses
Table 59. Caribou Biosciences Basic Information, Area Served and Competitors
Table 60. Caribou Biosciences Major Business
Table 61. Caribou Biosciences CRISPR-Cas9 Nuclease Product and Services
Table 62. Caribou Biosciences CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Caribou Biosciences Recent Developments/Updates
Table 64. Caribou Biosciences Competitive Strengths & Weaknesses
Table 65. CRISPR therapeutics Basic Information, Area Served and Competitors
Table 66. CRISPR therapeutics Major Business
Table 67. CRISPR therapeutics CRISPR-Cas9 Nuclease Product and Services
Table 68. CRISPR therapeutics CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. CRISPR therapeutics Recent Developments/Updates
Table 70. CRISPR therapeutics Competitive Strengths & Weaknesses
Table 71. Intellia therapeutics, Inc. Basic Information, Area Served and Competitors
Table 72. Intellia therapeutics, Inc. Major Business
Table 73. Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Product and Services
Table 74. Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Intellia therapeutics, Inc. Recent Developments/Updates
Table 76. Intellia therapeutics, Inc. Competitive Strengths & Weaknesses
Table 77. Horizon Discovery Plc Basic Information, Area Served and Competitors
Table 78. Horizon Discovery Plc Major Business
Table 79. Horizon Discovery Plc CRISPR-Cas9 Nuclease Product and Services
Table 80. Horizon Discovery Plc CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Horizon Discovery Plc Recent Developments/Updates
Table 82. Horizon Discovery Plc Competitive Strengths & Weaknesses
Table 83. Sigma Aldrich Basic Information, Area Served and Competitors
Table 84. Sigma Aldrich Major Business
Table 85. Sigma Aldrich CRISPR-Cas9 Nuclease Product and Services
Table 86. Sigma Aldrich CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sigma Aldrich Recent Developments/Updates
Table 88. Sigma Aldrich Competitive Strengths & Weaknesses
Table 89. Genscript Basic Information, Area Served and Competitors
Table 90. Genscript Major Business
Table 91. Genscript CRISPR-Cas9 Nuclease Product and Services
Table 92. Genscript CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Genscript Recent Developments/Updates
Table 94. Genscript Competitive Strengths & Weaknesses
Table 95. Integrated DNA Technologies Basic Information, Area Served and Competitors
Table 96. Integrated DNA Technologies Major Business
Table 97. Integrated DNA Technologies CRISPR-Cas9 Nuclease Product and Services
Table 98. Integrated DNA Technologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Integrated DNA Technologies Recent Developments/Updates
Table 100. Integrated DNA Technologies Competitive Strengths & Weaknesses
Table 101. New England Biolabs Basic Information, Area Served and Competitors
Table 102. New England Biolabs Major Business
Table 103. New England Biolabs CRISPR-Cas9 Nuclease Product and Services
Table 104. New England Biolabs CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. New England Biolabs Recent Developments/Updates
Table 106. New England Biolabs Competitive Strengths & Weaknesses
Table 107. Origene Technologies Basic Information, Area Served and Competitors
Table 108. Origene Technologies Major Business
Table 109. Origene Technologies CRISPR-Cas9 Nuclease Product and Services
Table 110. Origene Technologies CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Origene Technologies Recent Developments/Updates
Table 112. Origene Technologies Competitive Strengths & Weaknesses
Table 113. Aldevron Basic Information, Area Served and Competitors
Table 114. Aldevron Major Business
Table 115. Aldevron CRISPR-Cas9 Nuclease Product and Services
Table 116. Aldevron CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Aldevron Recent Developments/Updates
Table 118. Takara Bio Basic Information, Area Served and Competitors
Table 119. Takara Bio Major Business
Table 120. Takara Bio CRISPR-Cas9 Nuclease Product and Services
Table 121. Takara Bio CRISPR-Cas9 Nuclease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of CRISPR-Cas9 Nuclease Upstream (Raw Materials)
Table 123. CRISPR-Cas9 Nuclease Typical Customers
LIST OF FIGURES
Figure 1. CRISPR-Cas9 Nuclease Picture
Figure 2. World CRISPR-Cas9 Nuclease Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CRISPR-Cas9 Nuclease Total Market Size (2018-2029) & (USD Million)
Figure 4. World CRISPR-Cas9 Nuclease Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World CRISPR-Cas9 Nuclease Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 13. CRISPR-Cas9 Nuclease Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 16. World CRISPR-Cas9 Nuclease Consumption Value Market Share by Region (2018-2029)
Figure 17. United States CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 18. China CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 23. India CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of CRISPR-Cas9 Nuclease by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for CRISPR-Cas9 Nuclease Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for CRISPR-Cas9 Nuclease Markets in 2022
Figure 27. United States VS China: CRISPR-Cas9 Nuclease Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CRISPR-Cas9 Nuclease Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World CRISPR-Cas9 Nuclease Market Size by End Use, (USD Million), 2018 & 2022 & 2029
Figure 30. World CRISPR-Cas9 Nuclease Market Size Market Share by End Use in 2022
Figure 31. Genome Editing
Figure 32. Genetic Engineering
Figure 33. gRNA Database/Gene Librar
Figure 34. CRISPR Plasmid
Figure 35. Human Stem Cells
Figure 36. Genetically Modified Organisms/Crops
Figure 37. Cell Line Engineering
Figure 38. World CRISPR-Cas9 Nuclease Market Size Market Share by End Use (2018-2029)
Figure 39. World CRISPR-Cas9 Nuclease Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World CRISPR-Cas9 Nuclease Market Size Market Share by Application in 2022
Figure 41. Biotechnology Companies
Figure 42. Pharmaceutical Companies
Figure 43. Academic Institutes
Figure 44. Research and Development Institutes
Figure 45. CRISPR-Cas9 Nuclease Industrial Chain
Figure 46. Methodology
Figure 47. Research Process and Data Source
Figure 1. CRISPR-Cas9 Nuclease Picture
Figure 2. World CRISPR-Cas9 Nuclease Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CRISPR-Cas9 Nuclease Total Market Size (2018-2029) & (USD Million)
Figure 4. World CRISPR-Cas9 Nuclease Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World CRISPR-Cas9 Nuclease Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company CRISPR-Cas9 Nuclease Revenue (2018-2029) & (USD Million)
Figure 13. CRISPR-Cas9 Nuclease Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 16. World CRISPR-Cas9 Nuclease Consumption Value Market Share by Region (2018-2029)
Figure 17. United States CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 18. China CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 23. India CRISPR-Cas9 Nuclease Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of CRISPR-Cas9 Nuclease by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for CRISPR-Cas9 Nuclease Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for CRISPR-Cas9 Nuclease Markets in 2022
Figure 27. United States VS China: CRISPR-Cas9 Nuclease Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CRISPR-Cas9 Nuclease Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World CRISPR-Cas9 Nuclease Market Size by End Use, (USD Million), 2018 & 2022 & 2029
Figure 30. World CRISPR-Cas9 Nuclease Market Size Market Share by End Use in 2022
Figure 31. Genome Editing
Figure 32. Genetic Engineering
Figure 33. gRNA Database/Gene Librar
Figure 34. CRISPR Plasmid
Figure 35. Human Stem Cells
Figure 36. Genetically Modified Organisms/Crops
Figure 37. Cell Line Engineering
Figure 38. World CRISPR-Cas9 Nuclease Market Size Market Share by End Use (2018-2029)
Figure 39. World CRISPR-Cas9 Nuclease Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World CRISPR-Cas9 Nuclease Market Size Market Share by Application in 2022
Figure 41. Biotechnology Companies
Figure 42. Pharmaceutical Companies
Figure 43. Academic Institutes
Figure 44. Research and Development Institutes
Figure 45. CRISPR-Cas9 Nuclease Industrial Chain
Figure 46. Methodology
Figure 47. Research Process and Data Source
